6Q1.F CSAM HEALTH GROUP NK 10
- Market cap
- EUR 86.3M
- P/E
- -
- P/B
- 46.08x
- ROE
- -
- Dividend yield
- 1.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 6Q1.F undervalued?
Graham numberThe Graham number of CSAM HEALTH GROUP NK 10 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CSAM HEALTH GROUP NK 10 fundamental analysis
No fundamental analysis for CSAM HEALTH GROUP NK 10 yet.
CSAM HEALTH GROUP NK 10 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CSAM HEALTH GROUP NK 10
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storag…
Full company profileCSAM HEALTH GROUP NK 10 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CSAM HEALTH GROUP NK 10 annual financial statements (NOK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 329M | 367M | 410M | 425M | 494M | 492M |
| Gross Profit | 294M | 333M | 378M | 394M | 460M | 464M |
| Operating Income | -41.8M | -73.3M | -8.09M | -2.26M | 50.2M | 49.0M |
| EBITDA | - | -10.3M | 228M | 41.5M | 138M | 47.7M |
| Net Income | -86.6M | -132M | 104M | -66.7M | 6.61M | -68.6M |
| EPS | -4.13 | -6.28 | 5.11 | -3.25 | 0.32 | -3.35 |
| Balance Sheet | ||||||
| Total Assets | 856M | 694M | 769M | 788M | 805M | 720M |
| Total Liabilities | 684M | 665M | 674M | 771M | 779M | 740M |
| Shareholders' Equity | 172M | 28.8M | 95.3M | 17.1M | 26.7M | -20.2M |
| Cash & Short-term Investments | 275M | 192M | 117M | 118M | 83.8M | 33.3M |
| Cash Flow | ||||||
| Operating Cash Flow | 22.0M | 11.6M | 38.9M | 132M | 27.1M | -31.3M |
| Capital Expenditure | 28.6M | 41.9M | 46.4M | 44.0M | 48.9M | 41.1M |
| Free Cash Flow | -6.65M | -30.2M | -7.44M | 88.2M | -21.8M | -72.4M |
| Ratios | ||||||
| ROE | -50.4% | -457.4% | 109.5% | -391.3% | 24.8% | - |
| ROA | -10.1% | -19.0% | 13.6% | -8.5% | 0.8% | -9.5% |
| Net Profit Margin | -26.3% | -35.9% | 25.4% | -15.7% | 1.3% | -13.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CSAM HEALTH GROUP NK 10 dividends
- Dividend yield
- 1.03%
- Forward dividend
- 0.04 EUR
- Payout ratio
- -
- Ex-dividend date
- Apr 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | NOK 9.74M | 0.47 | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns CSAM HEALTH GROUP NK 10
- Insiders 48.22%
- Institutions 5.01%
- Public & others 46.78%
- Shares outstanding 20.5M
- Free float 7.37M
CSAM HEALTH GROUP NK 10 company profile
- Company name
- CSAM HEALTH GROUP NK 10
- Ticker
- 6Q1.F
- ISIN
- NO0010894512
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 249
- Fiscal year end
- December
- Address
- Drammensveien 288, Oslo, Norway, 0283
- Phone
- 47 22 94 15 90
- Website
- omda.com
About CSAM HEALTH GROUP NK 10
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a clinical imaging mobile application; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow solution; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, a patient data transfer tool; Omda Plutus, an audit and workflow monitoring platform; Omda S7, an e-care communications platform; and Omda XDS, a patient data storage and management solution. In addition, the company offers Omda Fertsoft, a data solution for advanced-assisted reproductive technology clinics; Omda iPana Hospital, a digital maternity solution; Omda iPana Maternity, a cloud-based platform for women's maternity care; and Omda Partus, a data solution for the maternity sector, as well as health analytics products comprising Omda Compos, a medical data management solution; and Omda MedSciNet for collection, analysis, and management of medical data. Further, it provides Omda Optima that enables emergency organizations to test resource distribution and operational strategy through digital simulations; Omda CoordCom, an integrated response management and complete reliability platform; Omda AMIS, a digital platform for processing emergency calls and coordinating various aspects of the medical response; and Omda Paratus, an emergency response system. The company was formerly known as CSAM Health Group AS and changed its name to Omda AS in September 2023. Omda AS was founded in 1999 and is headquartered in Oslo, Norway.
CSAM HEALTH GROUP NK 10 management
8- Mr. Sverre FlatbyChief Executive Officer
- Mr. Einar Torris BonnevieChief Financial Officer
- Oyvind TvildeChief Operating Officer
- Mr. Marius JohansenLegal Director
- Mr. Glenn Kenneth BruunChief Strategy Officer
- Mr. Leif Egil BuenChief Quality Officer
- Mr. Knut Ivar RødningenBusiness Unit Leader of Mobile Telemedicine
- Ms. Noor Al-Hashimi OlssonBusiness Unit Leader of Omda Incident